Results 161 to 170 of about 74,252 (184)

Uncommon Presentation of Mastocytosis: Focus on the Xanthelasmoid Variant. [PDF]

Cureus
Kozmane S, Baybay H, Tadlaoui A, Douhi Z, Mernissi F.   +4 more
europepmc   +1 more source

Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection.

Blood
Navarro-Navarro P, González-Tablas M, Pérez-Pons A, Sánchez-Muñoz L, Henriques A, Álvarez-Twose I, Nafria P, Araco-Sánchez D, Morales-Cabeza C, Caligaris H, Chen L, González-de-Olano D, González-López Ó, Escribano L, García-Montero AC, Jara-Acevedo M, Orfao A.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy

Annual Review of Pathology: Mechanisms of Disease, 2023
Wolfgang R Sperr, Dean D Metcalfe, Stephen J Galli   +2 more
exaly  

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Lancet, The, 2017
Olivier Lortholary, Cristina Bulai Livideanu, Carle F Paul   +2 more
exaly  

A new therapeutic advance for symptomatic systemic mastocytosis?

Lancet, The, 2017
Michel Arock
exaly  

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

New England Journal of Medicine, 2016
Jason Gotlib, Johanna C Kluin-Nelemans, Tracy I George   +2 more
exaly  

Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis

New England Journal of Medicine, 1993
Ruth Halaban
exaly  

Midostaurin in Advanced Systemic Mastocytosis

New England Journal of Medicine, 2016
Marie-Olivia Chandesris, Sp Chantepie, Emmanuel Gyan   +2 more
exaly